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Skeletal muscle retains a resident stem cell population called satellite cells. Although mitotically
quiescent in mature muscle, satellite cells can be activated to produce myoblast progeny to generate
myonuclei for skeletal muscle homoeostasis, hypertrophy and repair. Regulation of satellite cell
function in adult requires redeployment of many of the regulatory networks fundamental to
developmental myogenesis. Involved in such control of muscle stem cell fate in embryos are members
of the Pitx gene family of bicoid-class homeodomain proteins. Here, we investigated the expression and
function of all three Pitx genes in muscle satellite cells of adult mice. Endogenous Pitx1 was
undetectable, whilst Pitx2a, Pitx2b and Pitx2c were at low levels in proliferating satellite cells, but
increased during the early stages of myogenic differentiation. By contrast, proliferating satellite cells
expressed robust amounts of Pitx3, with levels then decreasing as cells differentiated, although Pitx3
remained expressed in unfused myoblasts. To examine the role of Pitx genes in satellite cell function,
retroviral-mediated expression of Pitx1, all Pitx2 isoforms or Pitx3, was used. Constitutive expression of
any Pitx isoform suppressed satellite cell proliferation, with the cells undergoing enhanced myogenic
differentiation. Conversely, myogenic differentiation into multinucleated myotubes was decreased
when Pitx2 or Pitx3 levels were reduced using siRNA. Together, our results show that Pitx genes play a
role in regulating satellite cell function during myogenesis in adult.
& 2013 Elsevier Inc. All rights reserved.Introduction
Skeletal muscle has a remarkable ability to repair and regenerate
due to the presence of resident stem cells, termed muscle satellite
cells, located on the surface of a myoﬁbre ((Mauro, 1961), for reviews
see (Relaix and Zammit, 2012; Scharner and Zammit, 2011)). Regula-
tion of satellite cell function during postnatal growth and in adult
requires redeployment of many regulatory networks key to control-
ling developmental myogenesis, for example Notch (Brohl et al.,
2012; Mourikis et al., 2012) and BMP signalling (Ono et al., 2011).
Other transcription factors involved in control of muscle stem cell fate
and myogenesis in embryos though, have not had their role in adult
muscle examined, including the transcription factors paired-like
homeodomain transcription factor 2 (Pitx2) and Pitx3 of the bicoid
class of homeodomain proteins (Abu-Elmagd et al., 2010; L’Honore
et al., 2007).
Pitx genes encode highly homologous proteins, virtually iden-
tical within their homeodomains and varying mainly in the
N-terminal region (Gage et al., 1999). Pitx2 and Pitx3 are involved
in development of several tissues, with Pitx2 being fundamental toll rights reserved.
mit).brain, pituitary, facial structures and heart development (Kioussi
et al., 2002; Kitamura et al., 1999, 1997; Lu et al., 1999; Muccielli
et al., 1996), whereas Pitx3 is central to eye and dopaminergic
neurone development (Qiu et al., 2008; Smidt et al., 2004, 1997).
Indeed, PITX mutations result in developmental disorders in man:
with PITX2 mutations causing Axenfeld-Rieger syndrome and
mutations in PITX3 underlying Anterior Segment Mesenchymal
Dysgenesis and congenital cataracts (Semina et al., 1998, 1996).
Both Pitx2 and Pitx3 are also implicated in developmental
myogenesis with myoblasts expressing Pitx2 and Pitx3 (Coulon
et al., 2007; Dong et al., 2006; L’Honore et al., 2007; Qiu et al.,
2008; Shih et al., 2007a). Indeed, Pitx2 can positively regulate Myf5
and MyoD expression, members of the myogenic regulatory factor
(MRF) family of transcription factors (comprising Myf5, MyoD, Mrf4
and myogenin) that are essential for myogenesis (Abu-Elmagd et al.,
2010; L’Honore et al., 2010). In head myogenesis in particular, Pitx2
actually initiates the myogenic program in extra-ocular muscles
(Dong et al., 2006; Shih et al., 2007a). Satellite cells express a
number of genes utilised during embryonic and foetal muscle
development, including the myogenic regulatory factors
(Beauchamp et al., 2000; Grounds et al., 1992; Yablonka-Reuveni
and Rivera, 1994), but little is known about the role of Pitx genes in
controlling adult myogenesis, other than Pitx2 and Pitx3 are
expressed in proliferating satellite cells (Ono et al., 2010).
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development and speciﬁcation of a number of tissues including ﬁrst
branchial arch derivatives, body wall and hind limb musculature
(Gage et al., 1999; Lanctot et al., 1997; Logan and Tabin, 1999; Szeto
et al., 1999), but it is unclear whether this is a direct effect on muscle
development. PITX1 is increased in muscle biopsies of patients with
Facioscapulohumeral muscular dystrophy (FSHD) (Dixit et al., 2007),
and transgenic muscle-speciﬁc PITX1 expression in mice results in a
dystrophic phenotype (Pandey et al., 2012).
Here, we examined the function of Pitx genes in adult muscle
satellite cells. Pitx1 was undetectable, while Pitx2 and Pitx3 were
modulated in a dynamic and complementary manner in murine
satellite cells. Pitx3 was expressed in the nuclei of proliferating
satellite cells, before being down-regulated later in myogenic
differentiation. However, unfused myoblasts retained Pitx3 pro-
tein. Pitx2 had a complementary proﬁle: being at low levels in
proliferating cells before being up-regulated during early myo-
genic differentiation, and being expressed in the nuclei of imma-
ture myotubes. To examine the effects of Pitx1, Pitx2a, Pitx2b,
Pitx2c or Pitx3 on myogenic progression in satellite cell-derived
myoblasts, we used retroviral-mediated expression. Such consti-
tutive expression revealed that all Pitx proteins suppressed
proliferation and enhanced myogenic differentiation. Conversely,
myogenic differentiation into multinucleated myotubes was
decreased when Pitx2 or Pitx3 levels were reduced using siRNA.
Together, our results demonstrate that Pitx2 and Pitx3 genes are
redeployed in satellite cells during myogenic progression, so
contributing to the regulation of satellite cells for their role in
maintenance and repair of skeletal muscle.Material and methods
Animals
Mice were bred, and experimental procedures carried out, in
accordance with British law under the provisions of the Animals
(Scientiﬁc Procedures) Act 1986, as approved by the King’s
College London Ethical Review Process committee. C57BL10 male
mice aged between 6 and 8 weeks were used for myoﬁbre and
satellite cell-derived myoblast preparations. Mice were sacriﬁced
by cervical dislocation.
Myoﬁbre isolation and culture
To study quiescent satellite cells and satellite cell-derived myo-
blasts retained on a myoﬁbre, extensor digitorum longus (EDL)
muscles were dissected and digested for 1.75 h in Dulbecco’s Mod-
iﬁed Eagle Media with Glutamax (DMEMGlutamax) (Invitrogen) with
v/v 1% pen/strep (Sigma) and 0.025% collagenase (Sigma) at 37 1C
with 5% CO2, before manual disruption with a wide bore glass pipette
(as previously described (Collins and Zammit, 2009)). Individual
liberated myoﬁbres were passed through 5% bovine serum albumin
(BSA) (Sigma) coated dishes with DMEMGlutamax (Invitrogen) with
v/v 1% pen/strep (Sigma) to remove debris. For non-adherent cultures,
myoﬁbres were transferred to 5% BSA (Sigma) coated dishes and
DMEMGlutamax (Invitrogen) with v/v 10% horse serum (HS) (Gibco),
v/v 0.5% chick embryo extract (CEE) (ICN Flow) and v/v 1% pen/strep
(Sigma) before being cultured at 37 1C with 5% CO2.
Satellite cell-derived myoblast preparation
To prepare plated satellite cell-derived myoblast cultures, myo-
ﬁbres were isolated and plated at 100 ﬁbres/well in 6 well plates
coated with 1mg/ml Matrigel (Collaborative Research). Muscle ﬁbres
were cultured in high-serum proliferation medium comprisingDMEMGlutamax (Invitrogen) with v/v 30% foetal bovine serum
(FBS) (PAA), 10% HS (Gibco), 1% CEE (ICN Flow), 10 ng/ml basic
ﬁbroblast growth factor (bFGF) (Peprotech) 1% pen/strep (Sigma), at
37 1C with 5% CO2 for 72 h, before being removed to leave the
satellite cell-derived myoblasts that had migrated from the myoﬁbre.
Myoblasts were then expanded for up to another 48 h. To assess
proliferation, myoblasts were cultured in high-serum medium (with-
out bFGF). To induce differentiation, myoblasts were cultured in low-
serum differentiation medium comprising of DMEMGlutamax (Invi-
trogen) with v/v 2% HS (Gibco) and 1% pen/strep (Sigma).Expression vectors
Murine Pitx cDNAs were cloned into a modiﬁed pMSCV-puro
vector (Clontech), in which the puromycin resistance gene has been
replaced with an internal ribosomal entry site preceding the coding
sequence for enhanced green ﬂuorescent protein (IRES-eGFP)
(Zammit et al., 2006). Murine Pitx1 and Pitx2a cDNA (kind gifts
from Dr Jacques Drouin) and Pitx2b and Pitx2c (kind gifts from Dr
Robert Kelly) were sub-cloned into pMSCV-IRES-eGFP. Pitx3 was
cloned from RNA extracted from proliferating satellite cell cultures.
All constructs were fully sequenced to ensure ﬁdelity. Retrovirus
was packaged in HEK293T cells in the presence of an ecotrophic
packaging plasmid, harvested from the culture medium and retro-
viral titre estimated. Retroviral constructs were tested using
Western blot analysis (Supplemental Fig. S1).Retroviral infection
Satellite cell-derived myoblasts were re-plated at 1.5105 cells
per well in 6 well dishes (Nunc) pre-coated with Matrigel (Collabora-
tive Research). Cells were maintained in high-serum proliferation
medium for 24 h before medium replacement and retroviral infection
1 h later. Cells were incubated at 37 1C under 5% CO2 with titered
control or Pitx-encoding retrovirus and 4 mg/ml polybrene for 4 h
before medium replacement to DMEMGlutamax (Invitrogen) with v/v
30% FBS (PAA), 10% HS (Gibco), 1% CEE (ICN Flow), 1% pen/strep
(Sigma). Cells were cultured for a further 24 h before being re-plated
5103 and 25103 cells/well on Matrigel (Collaborative Research)
coated 8-well chamber slides (Nunc), for proliferation and differentia-
tion assays respectively.siRNA-mediated Pitx gene knockdown
Satellite cell-derived myoblasts were re-plated at 1.5105
cells per well in 6 well dishes (Nunc) pre-coated with Matrigel
(Collaborative Research) and maintained in high-serum prolifera-
tion medium for 24 h. Medium was replaced with fresh medium
without antibiotic 1 h before siRNA transfection. Stealth siRNA
(Invitrogen) and Lipofectamine RNAiMAX (Invitrogen) transfec-
tion reagent was prepared as per manufacturer’s instructions to
give a ﬁnal working concentration of 30 nM Stealth siRNA. Stealth
siRNA against all Pitx2 isoforms, or Pitx3, were assessed for
speciﬁcity and efﬁcient knockdown of respective genes (supple-
mentary Fig. S2). The following siRNA were used in this study
Pan-Pitx2 (MSS276338) 50-CCAGCCUCAAUAGCCUGAAUAACUU-30
and Pitx3 (MSS237572) 50-UCUGGCUUCACAGCCUGUAUUCUCA-30
(Invitrogen). siRNA controls were purchased from Invitrogen. Cells
were cultured with transfection reagents for 6 h before medium
was replaced to high-serum proliferation medium for a further
24 h. Satellite cell-derived myoblasts were re-plated (as above)
for proliferation and differentiation assays.
Fig. 1. Dynamic Pitx2 and Pitx3 expression during myogenic progression in satellite cells. RNA was prepared from satellite cells manually stripped from extensor digitorum
longus (EDL) myoﬁbres immediately after isolation (quiescent) or after 24 or 72 h of activation in non-adherent culture. Myoﬁbres from both EDL muscles of 6 mice were
pooled to provide each of the 3 quiescent and 324 h replicates (n¼3), whilst pooled myoﬁbre cultures from both EDL muscles from 3 mice were cultured before
stripping to give 372 h samples (n¼3). Pitx2 and Pitx3 mRNA levels increased with culture compared to those in quiescent satellite cells when measured using
quantitative RT-PCR (A). Expression of Pitx2a, Pitx2b, Pitx2c and Pitx3 was directly compared after 72 h of culture and revealed that Pitx2c and Pitx3 were expressed at the
highest levels (B—expressed relative to Pitx2a). Differences in mRNA expression were tested using a two-tailed Student’s t-test, where an asterisk denotes po0.05.
Satellite cells associated with an isolated myoﬁbre were cultured for 72 h and co-immunostained with a speciﬁc Pitx2 antibody (red) and either Pax7 (green) or myogenin
(green) (C). Satellite cell progeny entering myogenic differentiation (myogenin-positive) were co-immunostained for Pitx2 (C—arrows). Myoﬁbre associated satellite cells
infected with Pitx2c-expressing retrovirus were used as a positive control and co-immunostained for eGFP (green) from the IRES-eGFP in the retroviral backbone, and Pitx2
(red) (D). Scale bar equals 100 mm.
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To assess endogenous gene expression in satellite cells, EDL
myoﬁbres were isolated from eight week old, male C57BL10 mice.
Muscle ﬁbres were either prepared immediately (4 h after sacriﬁce
and without exposure to serum) or after 24 and 72 h in culture, with
low-serum proliferation medium at 37 1C with 5% CO2. For eachreplicate (n¼3) ﬁbres from two mice (4 EDL muscles) were pooled,
mildly digested with 0.125% trypsin-EDTA (Sigma) for 12min, before
being manually stripped using a glass pipette to liberate satellite cells.
Subsequent passage through a 40 mm cell sieve (BD) separated
myoﬁbres and satellite cells.
Satellite cell-derived myoblasts were prepared as desc-
ribed previously, plated 1.5105 cells per well in Matrigel
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was extracted using the RNeasy Kit (Qiagen) and quantiﬁed on
a Nanodrop ND-1000 spectrophotometer (Labtech). cDNA
was prepared from 100 ng of RNA using the Reverse Transcription
Kit with genomic DNA wipeout (Qiagen). QPCR was performed on
an Mx3005P QPCR system (Stratagene) with MESA Blue qPCR
MasterMix Plus and ROX reference dye (Eurogentec).
Primers for Pitx2 isoforms, Pax7, Myf5, MyoD, myogenin
and MyHC have been previously described (Collins et al.,
2009, Martinez-Fernandez et al., 2006). Primers for Pitx1 (forward
50-TGGACCAACCTCACTGAACC-30 and reverse 50-CGCCCAGTT-
GTTGTAGGAGT-30), Pitx3 (forward 50-GAGCACAGTGACTCGGAGAA-30
and reverse 50-TGTCAGGGTAGCGATTCCTC-30) and Mrf4 (forward
50-TAAGGAAGGAGGAGCAAACG-30 and reverse 50-CCTGCTGGGTGAA
GAATGTT-30). Relative gene expression was calculated using the Pfafﬂ
method (Pfafﬂ, 2001) and signiﬁcance assessed with a Student’s
t-test.Immunostaining
Isolated myoﬁbres or plated myoblast preparations were ﬁxed
in 4% paraformaldehyde, permeabilised in 0.5% Triton X-100
(Sigma) for 10 min, washed then blocked in 10% v/v swine serum
(DAKO) and 10% v/v goat serum (DAKO) diluted in PBS for 30 min
at room temperature. Myoﬁbres or plated cultures were incu-
bated in primary antibodies overnight at 4 1C. The following day
samples were washed and primary antibodies detected using
AlexaFluor conjugated secondary antibodies (Invitrogen) at room
temperature for 1 h, before mounting in aqueous mountant
containing DAPI (Vectashield).
Primary antibodies used in this study include: mouse anti-Pax7
(DSHB), mouse anti-myogenin clone F5D (DSHB); mouse anti-
MyoD clone 5.8A (DakoCytomation), rabbit anti-GFP (Invitrogen),
rabbit anti-Phosphorylated-Histone H1 (Upstate/Millipore), rabbit
anti-Phosphorylated-Histone H3 (Upstate/Millipore), rat anti-Ki67
(DAKO) and chicken anti-GFP (Invitrogen). Well-characterised
rabbit polyclonal antibodies speciﬁc for either Pitx1, Pitx2 or Pitx3
were a kind gift from Dr. J. Drouin (L’Honore et al., 2007). The
speciﬁcity of these anti-Pitx antibodies was also independently
validated in this study by immunostaining cells expressing each
isoform using retroviral-mediated delivery, Western blot analysis,
and siRNA-mediated gene knockdown (Supplementary Fig. S1 and
Fig. S2). EdU was detected using the Click-iT EdU kit as per the
manufacturer’s instructions (Invitrogen).
Images of single ﬁbres were acquired on a Zeiss Axiovert 200 M
microscope using a Zeiss AxioCam HRm and AxioVision software
version 4.4 (Zeiss) and plated cultures using a Zeiss Axioplan 2 with
a Hamamatsu ORCA-ER camera with Openlab 3.1.7 software.
Images were adjusted globally for brightness and contrast.Immunoblot analysis
Satellite cell-derived myoblasts were prepared and infected as
described previously. Total protein was extracted, quantiﬁed and
10 mg of protein was used for the western blot. Primary antibodies
were rabbit polyclonal anti Pan-Pitx (from Jacques Drouin, 1/1000),
rabbit polyclonal anti-GFP (Invitrogen, 1/1000) and monoclonal
anti-ß-tubulin (E7-c, DHSB, 1/2000) were applied overnight at 4 1C
before washing and incubating with HRP-conjugated secondary
antibodies (anti-mouse IgG (NA931V, Ge Healthcare, 1/5000)), and
anti-rabbit IgG (NA934V, Ge Healthcare,1/5000) applied for 1 h at
room temperature. Bands were visualised using the ECL western
blotting detection reagents (GE Healthcare).Results
Pitx expression proﬁle in quiescent and activated satellite cells
Although Pitx expression has been detected in muscle pre-
cursors during development (Dong et al., 2006; L’Honore et al.,
2007; Shih et al., 2007a), little is known of the expression
dynamics (Ono et al., 2010) or function of Pitx genes during
myogenic progression in muscle satellite cells. We used the
isolated myoﬁbre model to explore Pitx expression in quiescent
and activated satellite cells, and in satellite cell-derived myoblasts
during proliferation and commitment to differentiation. Pitx2a,
Pitx2b, Pitx2c and Pitx3 mRNA were detected in quiescent satellite
cells stripped from freshly isolated EDL myoﬁbres and levels
increased on culture in activating medium (Fig. 1A), while Pitx1
could not be reliably detected. After 72 h in activation medium,
signiﬁcant increases in all Pitx2 isoforms and Pitx3 mRNA were
found (Fig. 1A). Using the Pfafﬂ method to account for different
primer efﬁciencies (Pfafﬂ, 2001), it was found that Pitx2c and Pitx3
mRNA were the most abundant Pitx isoforms in satellite cell-
derived myoblasts at 72 h (Fig. 1B).
To examine whether Pitx protein followed the gene expres-
sion dynamics, we used characterised antibodies against Pitx2
(detecting all Pitx2 isoforms) or Pitx3 (L’Honore et al., 2007). We
were unable to detect endogenous Pitx2 or Pitx3 protein in
quiescent or newly activated satellite cells associated with a
myoﬁbre, due to immunostaining background in the muscle
ﬁbre (data not shown). After 72 h in activation medium, many
satellite cell-derived myoblasts commit to differentiation and
express myogenin, whilst others retain Pax7, representing the
self-renewing population (Halevy et al., 2004; Zammit et al.,
2004). Pitx2 protein was clearly detectable in the nuclei of
myogenin positive satellite cell-derived myoblasts (Fig. 1C,
arrow), implicating Pitx2 in satellite cell differentiation. Anti-
body ﬁdelity was conﬁrmed by immunostaining cells infected
with retroviruses encoding Pitx1, Pitx2a, Pitx2b, Pitx2c or Pitx3,
and infection with a Pitx2c retroviral construct (that also
expresses eGFP via an IRES) is illustrated as an example of such
positive controls (Fig. 1D).
Pitx2 levels are up-regulated during myogenic differentiation
To investigate Pitx gene expression during proliferation, and then
throughout the differentiation program through to myoblast
fusion into multinucleate myotubes, satellite cells were isolated from
EDL myoﬁbres, expanded and then re-plated onto Matrigel-coated
culture dishes. Such satellite cell-derived myoblast cultures will
continue to proliferate, or can be induced to differentiate in
low-serum medium and after 12 h, begin to fuse into myotubes,
with the majority fusing to form multinucleate myotubes by 48 h
(Fig. 2A).
RNA was harvested from proliferating myoblasts, and from
those cultured for 6, 12, 24 and 48 h after addition of low-serum
differentiation medium. Pitx expression was assessed in parallel
with myogenic markers (Fig. 2B). As myoblasts differentiate,
expression of the transcription factors Pax7 and Myf5 decreased.
Conversely, myogenic factors associated with differentiation and
myotube maturation, such as myogenin and Mrf4, together with
myosin heavy chain (MyHC), all increased. MyoD levels were
already high in proliferating satellite cells and remained so during
the initial stages of myogenic differentiation, before then falling
as myotubes matured (Fig. 2B).
Pitx1 primer efﬁcacy was demonstrated using RNA isolated from
satellite cell-derived-myoblasts infected with a Pitx1-encoding
retrovirus (data not shown). However, endogenous Pitx1 expression
could not be reliably measured in satellite cell-derived myoblasts
Fig. 2. Pitx2mRNA levels increase during the early phases of differentiation in satellite cell-derived myoblasts. Proliferating plated satellite cell-derived myoblasts isolated
from extensor digitorum longus muscles were induced to differentiate in low-serum medium for 6, 12, 24 and 48 h, by which time they had fused to form multinucleated
myotubes (A—light ﬁeld). Scale bar equals 100 mm. Expression of myogenic genes (B) and Pitx transcription factors (C) was assessed during differentiation using
quantitative RT-PCR and displayed relative to mRNA levels in proliferating myoblasts (P). As expected Pax7 and Myf5 levels fell during differentiation when compared to
those in proliferating cells, while myogenin, MyHC and Mrf4 expression all increased (B). Levels of all Pitx2 isoforms increased during differentiation, while those of Pitx3
transiently rose, before then decreasing (C). Mean7SEM from 4 mice, where an asterisk denotes signiﬁcant difference (po0.05) in mRNA expression from that in
proliferating satellite cells using a two-tailed Student’s t-test.
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a signal (data not shown), which suggests that endogenous Pitx1
mRNA levels are negligible.
Compared to the levels in proliferating satellite cell-derived
myoblasts, expression of all Pitx2 isoforms signiﬁcantly increased
from12 h after induction of differentiation. After 24 h in differ-
entiation medium, levels of Pitx2a had increased 5.6 fold, Pitx2b3.3 fold and Pitx2c 5.9 fold (po0.05) compared to those measured
during proliferation (Fig. 2C).
A signiﬁcant increase in Pitx3 levels was measured in satellite
cell-derived myoblasts 6 and 12 h after the induction of
differentiation. However, Pitx3 mRNA levels then fell by a mean
of 36% at 24 h and 81% (po0.05) after 48 hrs in differentiation
medium, compared to levels in proliferating cells (Fig. 2C).
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of satellite cells
Immunostaining was also used to examine Pitx protein
distribution in proliferating and differentiating plated satellite
cell-derived myoblasts. There was weak nuclear immunostaining
for Pitx2 in Pax7-expressing proliferating satellite cell-derived
myoblasts, indicating the presence of low levels of Pitx2 protein
(Fig. 3A). After 24 h in differentiation medium however, the
immunosignal for Pitx2 protein was clearly stronger in MyoD ormyogenin expressing nuclei of satellite cell-derived myoblasts
(Fig. 3B—arrows), compared to myoblasts not expressing myo-
genin (Fig. 3B - arrowhead). This suggests that Pitx2 protein levels
are up-regulated around the time of induction of myogenin
expression. Quantiﬁcation of the number of cells that co-
immunostain for Pitx2 and myogenin showed that a mean7SD
of 8177.6% cells expressed both genes 24 h after induction of
differentiation, and 8777.6% (n¼3 mice) by 48 h. Pitx2 protein
was detected in the myogenin-positive nuclei of MyHC containing
multinucleated myotubes at 48 h (Fig. 3C—arrows).
Proliferating satellite cell-derived myoblasts exhibited robust
nuclear immunostaining for Pitx3 protein (Fig. 3D). However, 24 h
after induction of differentiation, decreased immunostaining for
Pitx3 protein in myogenin-positive myonuclei (Fig. 3E—arrows)
was observed, while myogenin-negative cells retained a Pitx3
immunosignal (Fig. 3E—arrowheads). Quantiﬁcation of the
number of cells that co-immunostain for Pitx3 and myogenin
(mainly weakly) showed that 6078.6% cells expressed both
genes 24 h after induction of differentiation, and 4573.8% (n¼3
mice) by 48 h. Although Pitx3 immunostaining was weak (or
absent) in many myotube nuclei, Pitx3 could still be detected in
the nuclei of a subset of non-fused, myogenin-negative cells
(Fig. 3F—arrowheads), which are likely reserve cells (Yoshida
et al., 1998).
Pitx proteins inhibit cell cycle progression
We next used retroviral-mediated constitutive expression of
Pitx1, Pitx2a, Pitx2b, Pitx2c or Pitx3, to examine effects on satellite
cell function. The retroviral constructs also contain an IRES-eGFP,
so that infected cells can be identiﬁed. Effects of infection with
retroviruses encoding each Pitx isoforms were compared to
infection with a control retrovirus expressing just eGFP. Although
Pitx1 was not detected convincingly at the mRNA or protein level
in satellite cells, we also assessed the effects of constitutive
expression of Pitx1, given its implication in FSHD muscle pathol-
ogy (Dixit et al., 2007). Constitutive expression using each of the
retroviral constructs produced enhanced levels of the relevant
Pitx isoform, together with eGFP controlled by the IRES, as
assayed using Western blot analysis (Supplementary Fig. S1).
To assess the effect of constitutive retroviral-mediated expres-
sion of Pitx transcription factors on proliferation, satellite cell-
derived myoblasts were isolated from EDL myoﬁbres, expanded in
high-serum proliferation medium, then re-plated to produce
parallel sister cultures. Cells were infected and 24 h after infec-
tion, satellite cell-derived myoblasts were assayed by either co-
immunostaining for Phosphorylated-Histone H1 and H3, or mea-
suring EdU incorporation (Fig. 4).
Phosphorylated-Histone H1 and H3 are dynamically regulated
through the cell cycle and the combined Phosphorylated-HistoneFig. 3. Pitx3 is expressed in proliferating myoblasts, while Pitx2 increases upon
myogenic differentiation. Plated satellite cell-derived myoblast cultures were
derived from isolated extensor digitorum longus myoﬁbres and maintained in
high-serum proliferation medium (A and D) or induced to differentiate for 24 (B and
E) or 48 h (C and F). Myoblasts were co-immunostained for Pitx2 or Pitx3 (green)
and either Pax7, MyoD, myogenin or MyHC (red). Pitx2 was at low levels in
proliferating satellite cells (A), but 24 h after induction of differentiation, strong
Pitx2 immunostaining was detected in myogenin-positive nuclei (B—arrows).
Myogenin-negative myoblast nuclei had comparatively low levels of Pitx2 protein
(B—arrowhead). 48 h after induction of differentiation, strong Pitx2 immunosignal
was detected in the nuclei of myotubes identiﬁed by myogenin or MyHC
immunostaining (C—arrows). Pitx3 was robustly expressed in proliferating myo-
blasts (D). Pitx3 levels remained robust in myogenin-negative cells during the early
stages of differentiation (E—arrowhead), but decreased in myogenin-positive nuclei
(E—arrows). By 48 h after induction of differentiation, Pitx3 levels were higher in
the nuclei of unfused myoblasts (F—arrowheads) than in the nuclei of myotubes.
Scale bar equals 20 mm.
Fig. 4. Constitutive Pitx expression reduces proliferation in satellite cell-derived myoblasts. Satellite cell-derived myoblasts from isolated extensor digitorum longus
myoﬁbres were infected with Pitx-encoding retroviral constructs or control retrovirus and maintained in high-serum proliferation medium for a further 24 h, before either
being co-immunostained for Phosphorylated-Histone H1 and H3 (A and B), or subjected to a 2 h EdU pulse (C). The expression pattern of Phosphorylated-Histone H1/H3
permits the stage of the cell cycle that a cell is in to be assessed (A). It was found that constitutive expression of Pitx1, Pitx2b, Pitx2c or Pitx3 signiﬁcantly increased the
proportion of cells in G0, compared to cells infected with control retrovirus (B—500 cells/infection/mouse, n¼4 mice). The percentage of infected eGFP-positive myoblasts
that had incorporated EdU was also quantiﬁed, and revealed that all Pitx isoforms, except Pitx2b, reduced the rate of proliferation compared to cells infected with control
retrovirus (C—mean 343 cells/infection/mouse, n¼3 mice). Mean7SEM are displayed where Signiﬁcant difference between infection with each Pitx isoform and control
retrovirus was tested using a two-tailed Student’s t-test, where an asterisk denotes po0.05.
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at in the cell cycle ((Hendzel et al., 1997; Lu et al., 1994) and
Fig. 4A). Constitutive expression of Pitx1, Pitx2b, Pitx2c or Pitx3
all signiﬁcantly increased the proportion of satellite cell-
derived myoblasts in G0, as compared to other stages of the
cell cycle, when compared to cells infected with control retrovirus
(Fig. 4B).
Constitutive retroviral-mediated expression of either Pitx1,
Pitx2a, Pitx2c, or Pitx3 in satellite cell-derived myoblasts also
signiﬁcantly decreased the percentage that incorporated EdU after
a 2-hour pulse immediately prior to ﬁxation, when compared to cells
infected with control retrovirus (Fig. 4C). This indicated that fewer
satellite cell-derived myoblasts had entered S-phase during the
duration of the EDU pulse.
Combined, these results show that expression of Pitx transcription
factors is sufﬁcient to suppress proliferation in expanded satellite cell-
derived myoblasts.Pitx proteins enhance myogenic differentiation
To examine the effects of constitutive Pitx expression during
myogenic differentiation through to fusion into multinucleated
myotubes, parallel sister cultures were infected with retroviral
constructs encoding either Pitx1, Pitx2a, Pitx2b, Pitx2c, Pitx3 or
control retrovirus. After 24 h in high-serum proliferation medium,
infected satellite cell-derived myoblasts were re-plated at equal
density and induced to differentiate using low-serum differentiation
medium for a further 48 h before ﬁxation and co-immunostaining
for either eGFP and Pax7, myogenin or MyHC (Fig. 5).
Constitutive expression of Pitx1, Pitx2a, Pitx2b, Pitx2c or Pitx3
resulted in an increase of fusion into multinucleated myotubes,
compared to infection with control retrovirus. 48 h after induc-
tion of differentiation, numerous thin eGFP/MyHC positive myo-
tubes were observed in cultures infected with Pitx-encoding
retroviral constructs (Fig. 5A). Pitx1, Pitx2a, Pitx2b, Pitx2c, or Pitx3
Fig. 5. Constitutive expression of Pitx1, Pitx2 or Pitx3 enhances myogenic differentiation in satellite cell-derived myoblasts. Satellite cell-derived myoblasts from isolated
extensor digitorum longus myoﬁbres were infected and 48 h after addition of low-serum differentiation medium, co-immunostained for eGFP (green) and either Pax7,
myogenin or MyHC (red). Constitutive expression of any Pitx gene increased the percentage of infected (eGFPþve) cells expressing myogenin (B) and the percentage of
nuclei included in eGFPþve multinucleated myotubes (A and C), compared to control-infected cultures (mean of 730 cells/infection/mouse assayed, n¼3 mice). However,
the percentage of eGFPþve myoblasts co-expressing Pax7 was signiﬁcantly reduced compared to control (D—mean of 1384 cells/infection/mouse assayed, n¼3/4 mice).
Mean7SEM is displayed, with signiﬁcant difference between constitutive expression of each Pitx isoform and the control retrovirus denoted with an asterisk, where
po0.05 when tested using a two-tailed Student’s t-test. Scale bar represents 50 mm.
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of eGFP-positive cells with myogenin when assayed 48 h after
induction of differentiation, to a mean7SEM of 93.072.5% for
Pitx1, 95.070.7% for Pitx2a, 90.071.5% for Pitx2b, 95.571.1% for
Pitx2c and 93.570.7% for Pitx3, compared to 83.670.9% in cells
infected with control retrovirus (po0.05, n¼3 mice—Fig. 5B).To ascertain if constitutive Pitx expression increased myoblast
fusion, the number of nuclei in eGFP-positive myotubes and non-
fused eGFP-positive myoblasts was counted 48 h after induction of
differentiation. Consistent with the increased number of nuclei
expressing the differentiation marker myogenin (Fig. 5B), infection
with any Pitx-encoding retroviral construct signiﬁcantly increased
Fig. 6. siRNA-mediated knockdown of Pitx2 or Pitx3 decreases myotube formation in satellite cell-derived myoblasts. siRNA were used to knock down Pitx2 isoforms
(siPan-Pitx2) or just Pitx3 (siPitx3) in proliferating satellite cell-derived myoblasts isolated from extensor digitorum longus muscles. 24 h after transfection with control,
Pan-Pitx2 or Pitx3 siRNA, proliferating satellite cell-derived myoblasts were pulsed for 2 h with EdU. Reducing levels of Pitx2 isoforms increased the proportion of cells
incorporating EdU (A—mean of 336 cells/siRNA/mouse assayed, n¼3 mice). Satellite cell-derived myoblast cultures transfected with control, Pan-Pitx2 or Pitx3 siRNA were
induced to differentiate and 48 h later, co-immunostained for MyHC and Ki67 (B–D). Either siPan-Pitx2 or siPitx3 reduced the percentage of satellite cell-derived
myoblasts fused to form myotubes (B and D—mean of 1592 cells/siRNA/mouse assayed, n¼3 mice) and increased the percentage of non-fused Ki67 proliferating cells
(C and D—mean 1592 cells/siRNA/mouse assayed, n¼3 mice). Mean7SEM from 3 mice is displayed, where an asterisk denotes signiﬁcant difference (po0.05) from
control siRNA-transfected cultures, using a paired two-tailed Student’s t-test. Scale bar equals 100 mm.
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eGFP-positive myotubes increasing to 85.072.9% after constitutive
Pitx1 expression, to 84.573.8% for Pitx2a, to 80.073.6% for Pitx2b,
to 88.471.0% for Pitx2c and to 87.471.4% by Pitx3, compared to
68.073.6% in controls (po0.05, n¼3 mice, Fig. 5C).
As constitutive expression of Pitx transcription factors incr-
eased myoblast differentiation, sister cultures were also co-immuno-
stained for eGFP and Pax7, and the number of non-fused myoblasts
quantiﬁed (Fig. 5D). A reduction in the number of Pax7-positive
myoblasts was observed 48 h after induction of differentiation
(Fig. 5D), consistent with the increase in myotube formation
(Fig. 5A and C). In control cultures, a mean7SEM of 21.572.5%
of eGFP-positive cells contained Pax7, but this was signiﬁcantly
reduced by constitutive expression of any Pitx isoform to o10%
(po0.05, n¼3/4 mice, Fig. 5D).
siRNA-mediated reduction of Pitx2 or Pitx3 levels suppress myogenic
differentiation
To next assess the effects of reducing Pitx2 or Pitx3 levels in
satellite cells, we used siRNA to either simultaneously knock down
all three Pitx2 isoforms (siPan-Pitx2) or just Pitx3 (siPitx3).
As endogenous levels of Pitx1 were found to be negligible in satellite
cell-derived myoblasts, siRNA knockdown was not performed. Totest the efﬁciency of knockdown, RNA was prepared from prolifer-
ating satellite cell-derived myoblasts isolated from EDL muscles
24 h after transfection with either Pan-Pitx2 or Pitx3 siRNA. There
was an 480% reduction in respective mRNA levels measured by
quantitative RT-PCR (Supplementary Fig. S2a). Satellite cell-derived
myoblasts, transfected with Pan-Pitx2, or Pitx3 siRNA were also
induced to differentiate for 48 h before cultures were co-
immunostained for Pitx2 or Pitx3 and myogenin. In control siRNA
transfected cultures, Pitx2 protein was detected in myotube nuclei,
whilst immunostaining in sister cultures exposed to Pan-Pitx2 siRNA
exhibited decreased nuclear immunostaining (Supplementary Fig.
S2b). In cultures transfected with control siRNA, strong Pitx3
immunosignal was detected in non-fused satellite cell derived
myoblasts, which was clearly reduced in sister cultures transfected
with Pitx3 siRNA (Supplementary Fig. S2c).
Expanded proliferating satellite cell-derived myoblasts were
transfected with control, Pan-Pitx2, or Pitx3 siRNA and 24 h later,
pulsed with EdU for 2 h and the proportion of cells incorporating
the label determined. Reducing the levels of Pitx2 isoforms
resulted in more cells incorporating EDU (Fig. 6A). Satellite
cell-derived myoblast cultures transfected with control, Pan-
Pitx2 or Pitx3 siRNA were also induced to differentiate by switch-
ing to low-serum medium, and 48 h later ﬁxed and co-
immunostained for MyHC and Ki67. Suppressing Pitx2 or Pitx3
P. Knopp et al. / Developmental Biology 377 (2013) 293–304302levels reduced the percentage of satellite cell-derived myoblasts
fused into myotubes (Fig. 6B and D) and increased the percentage
of non-fused Ki67-expressing proliferating cells (Fig. 6C and D).Discussion
Pitx genes have been shown to regulate skeletal muscle
development, and here we have examined if these three genes
also play a role in controlling myogenesis in adult. We found that
Pitx2 and Pitx3 are expressed in a dynamic fashion during
myogenic progression in muscle satellite cells, while Pitx1 was
undetectable at any stage. All Pitx2 isoforms were detectable in
proliferating satellite cell-derived myoblasts, with levels then
increasing during early myogenic differentiation. Pitx3 was
expressed in proliferating satellite cells, but levels then fell as
cells differentiated and fused into myotubes. Pitx3 protein how-
ever, remained detectable in myogenin-negative unfused cells.
Hitherto, examination of Pitx gene expression and function in
myogenesis has largely been conﬁned to development. In the
skeletal muscle lineage, Pitx2 is expressed in myoblasts concomi-
tantly with MyoD and myogenin in trunk and limb musculature
development, indicating that Pitx2 is present in the early phases of
myogenic differentiation (Coulon et al., 2007; L’Honore et al., 2007;
Qiu et al., 2008; Shih et al., 2007a; Shih et al., 2008). Pitx3 has been
detected in both myotome (possibly preceding MRF expression)
and in myogenin positive myoblasts of the developing limb
(L’Honore et al., 2007), as well as by b-galactosidase activity
in differentiated muscle of Pitx3nlacZ mice (Coulon et al., 2007).
In adult, we have previously shown that Pitx2 and Pitx3 message
can be detected in proliferating myoblasts (Ono et al., 2010), and
most muscles of adult Pitx2LacZ/þ mice exhibit robust reporter
expression (Shih et al., 2007b).
To examine both the effects of Pitx genes on satellite cell
function, and model potential increases of PITX1 in FSHD, we used
retroviral-mediated constitutive expression. Pitx1, Pitx2a, Pitx2b,
Pitx2c or Pitx3 all had similar effects: satellite cell proliferation
was reduced, while myogenic differentiation was promoted. There
is considerable sequence homology between Pitx genes: for exam-
ple, Pitx2 and Pitx3 are identical across their DNA binding home-
odomains (Gage et al., 1999). Furthermore, Pitx transcription factors
can bind and activate similar DNA targets (Gage and Camper, 1997;
Kitamura et al., 1997; Lamba et al., 2008; Tremblay et al., 2000), can
have shared synergistic partners (Poulin et al., 2000; Tremblay
et al., 2000) and Pitx isoforms can interact (Cox et al., 2002). When
constitutively expressed in sister cultures from a common
expanded primary satellite cell-derived myoblast preparation, there
is probably a similar repertoire of available target genes and co-
factors. The similarity in Pitx protein sequence presumably means
that they then activate the same cohort of genes, leading to the
common effect we observed of promoting differentiation. However,
at different points in myogenic progression, target gene or co-factor
availability and/or post-translational Pitx modiﬁcation (Briata et al.,
2003; Gherzi et al., 2010) could facilitate different roles for
endogenous Pitx2 and Pitx3 in satellite cells.
When Pitx2 or Pitx3 levels were reduced using siRNA, we
found that myogenic differentiation into multinucleated myo-
tubes was decreased, with more cells remaining in cell cycle.
Constitutive knockout of Pitx2 is embryonic lethal, with failure of
body wall closure, cranial facial and ocular defects, right pulmon-
ary isomerism and severe cardiac abnormalities (Kitamura et al.,
1999). However, conditional Pitx2 knockout in extraocular muscle
in adult mice has implicated Pitx2 in the maintenance of the
differentiated muscle phenotype (Zhou et al., 2009). By contrast,
deletion of Pitx3 does not affect mouse viability, with no drastic
effects on skeletal muscle during developmental myogenesis,possibly by virtue of up-regulation and compensation by Pitx2,
highlighting their overlapping and partially redundant roles in
myogenesis (L’Honore et al., 2007).
Pitx2 has been studied extensively in cardiac development
where there is evidence that it can act to either enhance (Ai et al.,
2006) or inhibit (Galli et al., 2008) cardiomyocycte proliferation.
In developing chick in vivo or in micromass cultures, overexpres-
sion of Pitx2 isoforms leads to an increased number of differ-
entiated myocytes, but whether this is direct, or due to enhanced
proliferation, is unclear (Abu-Elmagd et al., 2010).
Pitx gene function has also been widely investigated in
immortalised myoblasts. Consistent with our observations, knock-
down of Pitx2 in immortalised C2C12 myoblasts reduces MyoD
and myogenin expression, and inhibits myoblast differentiation
(Gherzi et al., 2010). However, Pitx2 can also promote cell
proliferation and Cyclin D1/D2 mRNA stabilisation in immortalised
myoblast cell lines (Briata et al., 2003; Kioussi et al., 2002; Lozano-
Velasco et al., 2011; Martinez-Fernandez et al., 2006). During
proliferation, Pitx2 associates with the Cyclin D1-stabilising com-
plex, but thymoma viral proto-oncogene 2 (Akt2)-mediated phos-
phorylation of Pitx2 occurs on induction of myogenic
differentiation and results in reduced Pitx2 association and desta-
bilisation of the complex (Briata et al., 2003; Gherzi et al., 2010).
Conversely the cyclin-dependent kinase inhibitor p21 has been
identiﬁed as a Pitx2 target gene (Cao et al., 2010; Shi et al., 2010).
To maintain proliferation, Pitx2 transcriptional activity is also
suppressed by the physical interaction of Tbx1 with the C-
terminus of Pitx2 (Cao et al., 2010). Thus, the phosphorylation
state of Pitx2, and/or protein interactions, can alter its function
during myoblast proliferation or differentiation. This implies that
Pitx2 is able to augment cell cycle arrest and differentiation in the
absence of pro-proliferative co-factors, whose reduction is an
important regulatory step for myoblast differentiation. In addition,
analysis of Pitx2 function in immortalised cell lines, that have
altered cell cycle regulation and a markedly reduced ability to
spontaneously differentiate, may exaggerate the importance of
Pitx2 during myoblast proliferation.
The moderate Pitx expression achieved in a large proportion of
cells using retroviral-mediated delivery in our study (Supplemen-
tal Fig. S1), rather than the high levels in relatively few cells after
transfection of plasmids, could also contribute to differences
between observations in expanded primary satellite cells and
immortalised cell lines (Kioussi et al., 2002; Lozano-Velasco et al.,
2011; Martinez-Fernandez et al., 2006). For example, transfection
of CMV-Pitx2c or CMV-Pitx3 expression vectors only have effects at
high doses in the immortalised Sol8 myoblast line. At low dose
(2 mg) there is a large increase in Pitx2c mRNA levels, but no
effects on proliferation or differentiation. At higher doses (4 or
8 mg—where 8 mg increases mRNA levels by 8000 fold), then
increased proliferation and inhibition of differentiation are
observed. Transfection of CMV-Pitx3 has no effects on prolifera-
tion at any dose (2, 4, or 8 mg), and only inhibits differentiation at
the highest level (4500 fold) (Lozano-Velasco et al., 2011).
In summary, this work has identiﬁed dynamic expression of
Pitx2 and Pitx3 in satellite cells from adult muscle and revealed
that they can act to promote cell cycle exit and augment
myogenic differentiation. Thus our data show that Pitx2 and Pitx3
can be added to the complex regulatory networks that not only
control muscle development (e.g. (L’Honore et al., 2007)), but also
play a role in regulating regenerative myogenesis.Acknowledgements
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